Moreover, expression levels of XIST have been correlated with patients’ survival in different kinds of cancers including bladder cancer, esophageal squamous cell carcinoma, nasopharyngeal carcinoma, lung cancer, gastric cancer, colorectal cancer and breast cancer. Here, XIST is linked to gastric cancer.